Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector
Committed to a Science-First Approach to Support Patient Access to Life-Changing Therapies
Veristat Welcomes Three New Leaders to Executive Team, Driving Global Growth and Regulatory Success in Clinical Research
Veristat Delivered a Full Range of Clinical Trial Services Culminating in Marketing Authorization of HIPRA’s SARS-CoV-2 Vaccine and...
Supporting Its Continued Commitment During Rare Disease Month to Making a Difference in the Lives of Patients Faced with Limited Treatment...
Highlights the unique advantages its DCT solutions hold for small to mid-size biotechs conducting trials for complex diseases
Advances commitment to support patient needs across diverse populations
Veristat’s Bold Thinking and World Class Clinical, Regulatory and Commercialization Capabilities Allow the Company to Successfully Tackle...